Press Releases from Biomarkers and Companion Diagnostics in Oncology Market (1 total)
Biomarkers and Companion Diagnostics in Oncology 2019| Abbott Molecular, Amoy Di …
Albany, NY, 30th January : Recent research and the current scenario as well as future market potential of "Biomarkers and Companion Diagnostics in Oncology" globally.
A biomarker is a defined molecular characteristic, for example a genetic mutation, that can tell a physician more about a patients disease state, or how they might respond to treatment. Predictive biomarkers indicate how likely a patient is to respond to a treatment, and are used…
